The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bernard, G.
Right arrow Articles by Bernard, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bernard, G.
Right arrow Articles by Bernard, A.

The Journal of Immunology, Vol 154, Issue 1 26-32, Copyright © 1995 by American Association of Immunologists

ARTICLES

The E2 molecule (CD99) specifically triggers homotypic aggregation of CD4+ CD8+ thymocytes

G Bernard, D Zoccola, M Deckert, JP Breittmayer, C Aussel and A Bernard
INSERM 343, Archet Hospital, Nice, France.

We have previously described E2 as a 32-kDa transmembrane glycoprotein displaying an isomorphism, as two epitopes (defined by mAbs O662 and L129) are widely distributed on T cells whereas two epitopes are restricted to T cell subsets (defined by mAbs D44 and 12E7). E2, the MIC-2 gene product, is involved in T cell adhesion because anti-E2 mAbs against pan T epitopes block spontaneous T cell rosettes. Pan T E2 mAbs are also able to induce exposure of the phosphatidylserine at the thymocyte surface but not at the surface of mature T lymphocytes, an event most likely linked to adhesion phenomena. We now show here that the anti-E2 mAbs (0662 and L129) that block rosettes and induce phosphatidylserine exposure at the thymocyte surface, and not those reacting with epitopes not involved in adhesion, also trigger aggregation of certain immature T cell lines and no other cell lines tested. Among the normal cells tested, anti-E2 mAbs exclusively induce homotypic aggregation of CD4+ CD8+ human thymocytes. This phenomenon is temperature, energy, and Mg++ dependent, and requires an intact cytoskeleton. These adhesion properties are rather characteristic of integrins. Nevertheless, mAb against beta 1, beta 2, and beta 3 integrin chains, as well as those against alpha-chains known to be present on thymocytes, are unable to block corticothymocyte aggregation. We conclude that E2 triggers on corticothymocytes and no other T cells a homotypic adhesion pathway most likely mediated by an uncharacterized integrin.


This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
E. J.A. van Wanrooij, P. de Vos, M. G. Bixel, D. Vestweber, T. J.C. van Berkel, and J. Kuiper
Vaccination against CD99 inhibits atherogenesis in low-density lipoprotein receptor-deficient mice
Cardiovasc Res, June 1, 2008; 78(3): 590 - 596.
[Abstract] [Full Text] [PDF]

Home page
 INT J SURG PATHOLHome page
D. Miliaras, S. Meditskou, and M. Ketikidou
Ossifying Fibromyxoid Tumor May Express CD56 and CD99: A Case Report
International Journal of Surgical Pathology, October 1, 2007; 15(4): 437 - 440.
[Abstract] [PDF]

Home page
 Clin. Cancer Res.Home page
J. H. Lee, S.-H. Kim, L.-H. Wang, Y.-L. Choi, Y. C. Kim, J. H. Kim, T. S. Park, Y.-C. Hong, and Y. K. Shin
Clinical Significance of CD99 Down-Regulation in Gastric Adenocarcinoma
Clin. Cancer Res., May 1, 2007; 13(9): 2584 - 2591.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H.-J. Byun, I.-K. Hong, E. Kim, Y.-J. Jin, D.-I. Jeoung, J.-H. Hahn, Y.-M. Kim, S. H. Park, and H. Lee
A Splice Variant of CD99 Increases Motility and MMP-9 Expression of Human Breast Cancer Cells through the AKT-, ERK-, and JNK-dependent AP-1 Activation Signaling Pathways
J. Biol. Chem., November 17, 2006; 281(46): 34833 - 34847.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A.-M. Imbert, G. Belaaloui, F. Bardin, C. Tonnelle, M. Lopez, and C. Chabannon
CD99 expressed on human mobilized peripheral blood CD34+ cells is involved in transendothelial migration
Blood, October 15, 2006; 108(8): 2578 - 2586.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
M. C. Manara, G. Bernard, P.-L. Lollini, P. Nanni, M. Zuntini, L. Landuzzi, S. Benini, G. Lattanzi, M. Sciandra, M. Serra, et al.
CD99 Acts as an Oncosuppressor in Osteosarcoma
Mol. Biol. Cell, April 1, 2006; 17(4): 1910 - 1921.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
P. L. W. Yun, A. A. DeCarlo, and N. Hunter
Gingipains of Porphyromonas gingivalis Modulate Leukocyte Adhesion Molecule Expression Induced in Human Endothelial Cells by Ligation of CD99
Infect. Immun., March 1, 2006; 74(3): 1661 - 1672.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
G. Bixel, S. Kloep, S. Butz, B. Petri, B. Engelhardt, and D. Vestweber
Mouse CD99 participates in T-cell recruitment into inflamed skin
Blood, November 15, 2004; 104(10): 3205 - 3213.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. D. Pettersen, G. Bernard, M. K. Olafsen, M. Pourtein, and S. O. Lie
CD99 Signals Caspase-Independent T Cell Death
J. Immunol., April 15, 2001; 166(8): 4931 - 4942.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Scotlandi, N. Baldini, V. Cerisano, M. C. Manara, S. Benini, M. Serra, P.-L. Lollini, P. Nanni, G. Nicoletti, G. Bernard, et al.
CD99 Engagement: An Effective Therapeutic Strategy for Ewing Tumors
Cancer Res., September 1, 2000; 60(18): 5134 - 5142.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
O. Mandelboim, P. Malik, D. M. Davis, C. H. Jo, J. E. Boyson, and J. L. Strominger
Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity
PNAS, May 11, 1999; 96(10): 5640 - 5644.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
H. W. Sohn, E. Y. Choi, S. H. Kim, I.-s. Lee, D. H. Chung, U. A Sung, D. H. Hwang, S. S. Cho, B. H. Jun, J. J. Jang, et al.
Engagement of CD99 Induces Apoptosis Through a Calcineurin-Independent Pathway in Ewing's Sarcoma Cells
Am. J. Pathol., December 1, 1998; 153(6): 1937 - 1945.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Waclavicek, O. Majdic, T. Stulnig, M. Berger, R. Sunder-Plassmann, G. J. Zlabinger, T. Baumruker, J. Stockl, C. Ebner, W. Knapp, et al.
CD99 Engagement on Human Peripheral Blood T Cells Results in TCR/CD3-Dependent Cellular Activation and Allows for Th1-Restricted Cytokine Production
J. Immunol., November 1, 1998; 161(9): 4671 - 4678.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. Y. Choi, W. S. Park, K. C. Jung, S. H. Kim, Y. Y. Kim, W. J. Lee, and S. H. Park
Engagement of CD99 Induces Up-Regulation of TCR and MHC Class I and II Molecules on the Surface of Human Thymocytes
J. Immunol., July 15, 1998; 161(2): 749 - 754.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.